retatrutide clinical trials news Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide UK: 2026 Clinical Trial

4n, Table 2)

These findings were confirmed in high-fat, high-cholesterol (HFHC) dietfed mice with functional LDL receptor deficiency induced by viral expression of proprotein convertase subtilisin/kexin type 9adeno-associated virus (PCSK9-AAV), in which daily administration of semaglutide for 18 weeks reduced aortic plaque area (11)

This means that while you are in ketosis, your body natural GLP-1 production decreases

Patel, Y

GLP-1 receptor agonists work by activating the GLP-1 receptors, which stimulate insulin secretion and decrease glucagon release, leading to better glycemic control

#glp1weightloss #glp1forweightloss #ozpempicjourney #pcos Still struggling to get my daily value of fiber and protein